启明颗粒治疗干眼症的有效性与安全性:系统评价与Meta分析
该系统评价与Meta分析检索三个英文数据库和四个中文数据库,纳入11篇文献,方法学质量较低。结果显示启明颗粒对干眼症有效(RR:1.26,95%CI:1.12至1.41,P=0.0001),可延长泪膜破裂时间、增加泪液量并修复角膜缺损,但作者认为尚不能确认其疗效,需更多高质量研究。
要点
- 启明颗粒对干眼症显示出统计学显著的有效性,但纳入研究方法学质量低。
- 启明颗粒可延长泪膜破裂时间、增加泪液量并修复角膜缺损。
- 目前证据尚不足以确认启明颗粒治疗干眼症的疗效,需更多高质量研究。
核心结论
- 尽管部分结局指标显示明显阳性结果,但确认启明颗粒治疗干眼症的疗效为时尚早,未来仍需更多高质量研究进一步证实其有效性与安全性。
研究设计与样本
- 系统评价与Meta分析,检索三个英文数据库和四个中文数据库,不限制语言和发表偏倚,最终纳入11篇文章,纳入研究的方法学质量较低。
主要发现
- 启明颗粒对干眼症有效(RR:1.26,95%CI:1.12至1.41,P=0.0001)。
- 随机效应模型合并结果显示,启明颗粒可显著延长泪膜破裂时间(MD:2.93,95%CI:2.22至3.65,P<0.00001)。
- 启明颗粒可增加干眼症患者的泪液量(MD:2.94,95%CI:1.83至4.04,P<0.00001)。
- 启明颗粒可修复患者角膜缺损(MD:-0.71,95%CI:-1.25至-0.17,P<0.00001)。
临床怎么用
- 临床可参考该系统评价结果,在干眼症患者中考虑使用启明颗粒以改善泪膜破裂时间、泪液量和角膜缺损,但需结合患者具体情况并告知证据质量较低。
局限性
- 纳入研究的方法学质量较低,语言和发表偏倚未受限,且作者认为尚不能确认启明颗粒治疗干眼症的疗效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Dry eye disease (DED) is a common complication in clinical practice. Qiming granule, a traditional Chinese patent medicine, is widely used in treating DED in China. However, its effect is still largely unknown. OBJECTIVES: This research aims to evaluate the efficacy and safety of QG on DED. METHODS: Three English database and four Chinese databases without restriction on language and publication bias were searched. Qualified literature was selecting according to inclusion and exclusion criteria, extracted the data, and conducted a meta-analysis. RESULTS: A total of 11 articles were included in this meta-analysis. The methodological quality of included studies was low. The results showed that QG was effective for DED (RR:1.26, 95%CI:1.12 to 1.41, P=0.0001). The results combined with random effects model showed that QG could significantly prolong the tear film break up time (MD: 2.93, 95% CI: 2.22 to 3.65, P < 0.00001), increase the amount of tears in patients with DED (MD: 2.94, 95% CI: 1.83 to 4.04, P < 0.00001) and repair the corneal defects in patients (MD: -0.71, 95% CI: -1.25 to -0.17, P < 0.00001). CONCLUSIONS: This study found that despite of the apparently positive results of some outcomes, it is premature to confirm the efficacy of QG in treating DED. More high-quality studies are still needed in the future to further confirm the efficacy and safety.
引用
- Yang M, Hu Z, Yue R, et al. The Efficacy and Safety of Qiming Granule for Dry Eye Disease: A Systematic Review and Meta-Analysis. Front Pharmacol. 2020. PMID: 32425798. doi:10.3389/fphar.2020.00580
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。